Top 10 Pharmaceutical Companies In India

India is currently the largest supplier of generic drugs, has a 20% market share in global supply by volume, and meets nearly 60% of vaccine requirements worldwide. Pharmaceutical Companies In India also supply 80% of antiretroviral drugs (used to fight AIDS) in international markets.

The ongoing pandemic has led to an increase in the number of healthcare facilities as new and old pharmaceutical companies in India serve the enormous needs of society.

The international pharmaceutical market is expected to exceed US $ 1.5 trillion by 2023. India enjoys a vital position in the global pharmaceutical market. India provides more than 50% of the world's need for various vaccines and 40% of the demand for generics in the United States.

India's pharmaceutical spending is expected to expand at a compound annual growth rate of 8-11% during the period 2019-23 to reach US $ 28-32 billion.

Top 10 Pharmaceutical Companies in India in 2020 are:

Sun Pharmaceutical Industries Ltd.

Sun Pharma offers formulations in many therapeutic fields, including Cardiology, Diabetes, Neurology, Gastroenterology, and Psychiatry. The company also supplies APIs such as etodolac, clorazepate, carbamazepine, and warfarin. It also provides anticancer drugs, peptides, steroids, sex hormones, etc.

Sun Pharmaceutical Industries Limited is an Indian multinational pharmaceutical company ranked in the top 10 pharmaceutical companies, producing and selling pharmaceuticals as well as active pharmaceutical ingredients (APIs) in India and the United States. The company's total sales amounted to Rs 29,066 million. The company is one of the most trusted and reputable pharmaceutical companies in India.

The company offers more than 2000 formulations and also exports to several other countries. India Management Association (AIMA) Entrepreneur of the Year Award in 2017, awarded to Sun Pharma

Sun Pharmaceuticals Features:

• World-class research and development facilities.
• Private API

Dr. Riddes Laboratories Ltd.

Dr. Reddy Laboratories is an Indian multinational pharmaceutical company. The company produces and markets a wide range of pharmaceutical products in India and abroad. The company has more than 190 drugs and 60 APIs for the manufacture of pharmaceuticals, biotech products, intensive care and diagnostic kits.

The company has seven active factories across India. The company took its first step and expanded its operations to Russia in 1992.

To combat this COVID-19 pandemic, Dr. Reddy Laboratories agreed to conduct the final phase clinical trials of the Russian Sputnik V COVID-19 vaccine in India. They are intended to produce up to 100 million doses after successfully completing clinical trials and regulatory approvals.

Divi Labs

Divis Laboratories manufactures predominantly export APIs, modulators and nutraceutical ingredients.

Divi Laboratories has two manufacturing systems and is among the leading pharmaceutical companies in the country.

Due to its market value, it has made it to the list of the best pharmaceutical companies in India. They have three manufacturing units and 3 R&D units.

Divi's Labs is among the youngest companies, leading to its inclusion in the list of leading pharmaceutical companies. The company exports products to countries such as the United States, Europe, Japan, South Africa, Australia and the Philippines.

Cipla

Cipla is a leading global pharmaceutical company, committed to the highest quality generic drugs. The company is trusted by healthcare professionals and patients around the world.

The company offers a wide range of medicines. The company has secured a prominent position in the Indian market and in the world market. The company is distributed in 150 countries.

By adhering to the highest quality standards, the company has earned global recognition, as well as approvals from major global regulatory agencies.

Cipla Features:

• The company offers more than 2000 combinations.
• The company covers areas such as neurology, nephrology and diabetes.
• The company offers products of the best quality.

The company has strengthened its global focus by consolidating and strengthening its presence in important markets in India, the United States and South Africa.

Aurobindo Pharma

Aurobindo Pharma started operations in 1988-89 with a single semi-synthetic penicillin manufacturing unit in Pondicherry.

The company became a public company in 1992. In addition to semisynthetic penicillins, the company is present in the main therapeutic sectors such as cardiovascular, antiretrovirals, neuroscience, antibiotics, gastroenterology, antidiabetics, antiallergics, etc. .

The company exports its products to more than 150 countries around the world. Aurobindo pharma has production, research and development units.

The products offered by this company are efficient and economical, these products are of high quality and are in great demand in the market.

Advantages of Aurobindo Pharma:

• Multiple product portfolio
• Wide range of products
• World-class research and development facilities

Torrent medicine

Torrent Pharma pioneered the beginning of specialty marketing in India. Today, it is among the pioneers in the therapeutic field of women's health, cardiovascular, central nervous and digestive systems.

Additionally, the company has a significant presence in the diabetes, oncology, gynecology, pain management and anti-infectives sectors.

They have first-class manufacturing centers, advanced research and development facilities, an extensive national network, and an international presence that is prevalent in more than 40 countries.

The company bought Indian Elder Pharma in 2013, Derm Pharmaceutical for Zyg Pharma in 2015, API Plant for Glochem Industries in 2016, Novartis' Women Healthcare Brands, Indian-brand Unichem together with Sikkim Factory in 2017.

Furthermore, Torrent acquired the generic drug company Bio-Pharm, Inc and the OTC Company in January 2018.

The company deals with a wide range of products including the central nervous system, cardiovascular system, diabetes, digestive system, pain management and infection control sectors.

The company has its own manufacturing system in various parts of the country. The company has subsidiaries all over the world. In 2005, the company acquired Heumann GmbH, a subsidiary of Pfizer.

Lupine Ltd

Lupine is a global pharmaceutical company that offers a wide range of products, such as generic and brand formulations, biotech products, APIs, etc. The company's manufacturing centers are located in India, Japan, Brazil, Mexico and the United States.

The company is a major player in the fields of non-steroidal anti-inflammatory drugs, cardiovascular drugs, central nervous system, gynecology, asthma, pediatrics, diabetes, gastrointestinal drugs, and anti-infectives.

In addition, the company occupies an international leadership position in the tuberculosis and cephalosporins sectors. The company is distributed in 100 countries. It provides high-quality yet inexpensive drugs for some of the most persistent ailments that meet unmet demands in many parts of the world.

Characteristics of lupine drugs:

• The company offers a wide range of products.
• Lupine Pharmaceuticals produces powerful APIs.
  
  

Zydus Cadila Health Care